Understanding Hypertension

Understanding Hypertension

---

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers before starting new treatments and for all medical decisions. Never delay seeking medical care based on content you have read.

These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.

---

In Brief

Hypertension is not a number on a cuff. It is sustained mechanical force applied to every artery in the body, thousands of times per day, usually without symptoms. The arterial system tolerates normal pulsatile pressure indefinitely; it does not tolerate chronically elevated pressure without remodeling, stiffening, and accumulating injury. The danger is not what any single reading shows — it is what years of sustained pressure do to vascular tissue, usually well before clinical disease appears. This article explains what blood pressure is, how the body regulates it, and how sustained elevation injures the heart, brain, kidneys, aorta, eyes, and microcirculation.

---

The Circulatory System: Delivering Blood to Every Cell

Every cell in the body requires a constant supply of oxygen and nutrients to survive. The circulatory system exists to meet this demand. It is a closed loop of blood vessels — arteries, capillaries, and veins — through which the heart pumps blood continuously, beating roughly 100,000 times per day. (1)

The heart sits at the center of this system. It is a muscular pump divided into four chambers: the right atrium and right ventricle, which receive blood from the body and send it to the lungs; and the left atrium and left ventricle, which receive oxygenated blood from the lungs and pump it out to the rest of the body.

When the left ventricle contracts, it ejects blood into the aorta — the largest artery in the body. From the aorta, blood flows into progressively smaller arteries that branch throughout the body, eventually reaching the capillaries: microscopic vessels where oxygen and nutrients pass into tissues, and carbon dioxide and waste products pass back into the blood. The blood then returns to the heart through the veins, completing the circuit.

This continuous circulation is what keeps every organ alive — the brain, kidneys, muscles, skin, and the heart itself. For blood to flow through this extensive network, it must be under pressure.

Arteries are built to tolerate normal pulsatile flow indefinitely, but not sustained excess pressure. When pressure stays elevated over years, the same force that keeps organs alive begins to damage them.

---

Why Blood Pressure Is Necessary

Blood pressure is the force that blood exerts against the walls of arteries as it flows through them. This force is essential. Without it, blood would not move forward through the arterial system, and tissues would not receive the oxygen and nutrients they need to function.

A plumbing analogy: the pump (the heart) creates pressure that pushes fluid (blood) through the pipes (arteries) to reach every faucet (organ and tissue). If pressure is too low, flow is inadequate. If pressure is too high, the pipes are stressed.

Blood pressure is not static. It fluctuates with every heartbeat. When the heart contracts and ejects blood, pressure rises. When the heart relaxes between beats, pressure falls. These two phases give us the two numbers in a blood pressure reading.

What the numbers mean

Systolic pressure (the top number) is the peak pressure in the arteries during ventricular contraction — when the heart ejects blood into the aorta. This is the maximum force the arterial walls experience with each heartbeat.

Diastolic pressure (the bottom number) is the minimum pressure in the arteries between heartbeats — when the heart is relaxed and refilling. This represents the baseline pressure the arterial walls are always under.

A blood pressure reading of 120/80 mmHg means pressure peaks at 120 mmHg during contraction and falls to 80 mmHg between beats. Both numbers carry information about cardiovascular risk. (2)

Blood pressure is measured in millimeters of mercury (mmHg) — a unit that dates back to early pressure-measuring devices that used columns of mercury.

---

How the Body Generates Blood Pressure

Blood pressure is determined by two fundamental factors: (3)

Blood Pressure = Cardiac Output × Peripheral Vascular Resistance

Cardiac output is the volume of blood the heart pumps per minute. It depends on how fast the heart beats (heart rate) and how much blood it ejects with each beat (stroke volume). At rest, cardiac output is typically about 5 liters per minute, meaning the heart pumps the entire blood volume through the body roughly once every minute. (1,4)

Peripheral vascular resistance is the resistance blood encounters as it flows through the arterial system. Most of this resistance comes from the small arteries called arterioles, which can constrict or dilate to regulate blood flow. When arterioles constrict, resistance rises and blood pressure rises with it. When they dilate, resistance falls and blood pressure falls.

In practical terms, blood pressure rises when the heart is pushing more blood forward, when the arteries are tighter and more resistant, or when both are happening together. Most forms of hypertension involve some combination of increased vascular resistance, abnormal sodium handling, sympathetic activation, vascular stiffening, and long-term resetting of the body’s pressure-control systems. Most blood pressure medications work by reducing cardiac output, vascular resistance, or both.

The anatomy of arteries

Arteries are not passive pipes. They are dynamic, living structures designed to handle the pulsatile flow of blood. Understanding their anatomy helps explain how hypertension causes damage.

Layer	Location	Function
Intima	Innermost	Lined by endothelium; regulates vascular tone, prevents clots, controls inflammation, and determines what enters the arterial wall (5)
Media	Middle	Smooth muscle and elastic fibers; contracts and relaxes to change diameter and absorb pulsatile force (5)
Adventitia	Outermost	Structural support; anchors artery to surrounding tissues (5)

Large arteries like the aorta are highly elastic, designed to absorb the force of each heartbeat. As arteries branch and become smaller, they become more muscular and less elastic, allowing them to regulate blood flow to specific tissues. (5)

---

How the Body Regulates Blood Pressure

The body uses multiple overlapping systems to keep blood pressure within a viable range. These systems operate over different time scales — from seconds to weeks — and work together to ensure adequate blood flow to vital organs.

System	Time scale	What it does
Baroreceptor reflex	Seconds	Pressure sensors in arteries signal the brainstem to adjust heart rate and vascular tone (6)
Sympathetic nervous system	Minutes to hours	Increases heart rate, cardiac contraction, and vasoconstriction (8)
Renin–angiotensin–aldosterone system (RAAS)	Hours to days	Hormonal cascade causing vasoconstriction and sodium/water retention (10)
Kidneys	Days to weeks	Adjust sodium and water excretion to control blood volume (11)

These systems overlap continuously rather than functioning independently.

Immediate regulation: the baroreceptor reflex

Specialized pressure sensors called baroreceptors are located in the walls of the carotid arteries and the aortic arch. These sensors detect changes in blood pressure and send signals to the brainstem, which adjusts heart rate and vascular tone within seconds. (6)

When you stand up from lying down, blood pools in your legs due to gravity, and blood pressure in the upper body drops. The baroreceptors sense this immediately and trigger an increase in heart rate and vasoconstriction to restore pressure. This is why you don’t faint every time you stand up.

In chronic hypertension, baroreceptors can “reset” to accept a higher pressure as normal. (7) This is the first hint of one of the most important biological facts about hypertension: the feedback system that should correct elevated pressure begins to defend it instead.

Short-term regulation: the sympathetic nervous system

The sympathetic nervous system — the “fight or flight” system — raises blood pressure by increasing heart rate, strengthening cardiac contraction, and constricting blood vessels. This response is appropriate during exercise, stress, or emergencies. (8)

Many people with hypertension have chronically elevated sympathetic activity, particularly those with obesity, obstructive sleep apnea, or chronic psychological stress. (9) What evolved as a short-term survival response becomes a long-term contributor to vascular injury. This does not mean stress is the sole cause of hypertension, but chronic sympathetic activation can contribute meaningfully in susceptible individuals.

Intermediate regulation: the renin–angiotensin–aldosterone system

When the kidneys sense decreased blood flow or low sodium delivery, they release renin, triggering a cascade: (10)

Renin → Angiotensin I → Angiotensin II (via ACE) → Aldosterone

Angiotensin II is a powerful vasoconstrictor — it tightens blood vessels throughout the body, raising blood pressure. It also stimulates thirst, promotes sodium retention, and over time contributes to structural remodeling of the heart and blood vessels.

Aldosterone acts on the kidneys to retain sodium and water, expanding blood volume and raising pressure.

RAAS activation raises blood pressure both by tightening blood vessels and by increasing blood volume — two reinforcing effects acting together.

This system evolved to protect blood pressure during dehydration or blood loss — short-term survival events. In hypertension, it is often inappropriately active over years. Several medication classes — ACE inhibitors, ARBs, and mineralocorticoid receptor antagonists — work by blocking different steps in this cascade. (10)

Long-term regulation: the kidneys

The kidneys are the ultimate long-term regulators of blood pressure through their control of sodium and water balance. (11)

When blood pressure rises, healthy kidneys excrete more sodium and water in the urine — a phenomenon called pressure natriuresis — which reduces blood volume and lowers pressure. When blood pressure falls, the kidneys retain sodium and water.

In hypertension, this relationship is shifted: the kidneys require a higher pressure to excrete the same amount of sodium. (11) The “set point” has moved upward, influenced by genetics, RAAS activation, sympathetic tone, and nephron number. (12,13) Effectively, the kidney–hormone control system behaves as if a higher pressure is what’s needed to maintain sodium balance.

---

Why the Body Defends Elevated Pressure

One of the most important concepts in hypertension is that the body gradually begins defending the elevated pressure rather than correcting it. Baroreceptors reset to accept higher values as normal. The kidneys require higher pressures to excrete sodium. Sympathetic activity remains elevated. Arteries stiffen and transmit pulsatile force more directly. What began as an adaptive response — a system designed to maintain perfusion during physiologic stress — gradually becomes the new biological baseline.

The systems that regulate blood pressure evolved primarily to protect survival during dehydration, hemorrhage, infection, and physical exertion. In modern hypertension, many of these same systems remain chronically activated long after the original adaptive purpose has passed. A system designed for short-term survival remains activated long-term.

This explains why hypertension rarely resolves on its own. Once the set point has shifted upward, every regulatory system that should pull it back down is calibrated to keep it where it is. Treatment helps interrupt and reset systems that have adapted to maintaining higher pressure.

---

What Is Hypertension?

Hypertension — commonly called high blood pressure — is a condition in which blood pressure is persistently elevated above normal levels. It is not a single high reading. It is a pattern confirmed over time.

The 2025 AHA/ACC blood pressure categories (unchanged from the 2017 guideline that it retired and replaced): (14)

Category	Reading	Clinical implication
Normal	<120 mmHg and <80 mmHg	Lowest observed risk (14)
Elevated	120–129 mmHg and <80 mmHg	Increased risk; lifestyle emphasis (14)
Stage 1 hypertension	130–139 mmHg or 80–89 mmHg	Treatment depends on overall risk (14)
Stage 2 hypertension	≥140 mmHg or ≥90 mmHg	Medication commonly used (14)
Hypertensive crisis	≥180 mmHg and/or ≥120 mmHg	Requires urgent assessment (14)

European guidelines (ESC/ESH) retain 140/90 mmHg as the primary definition in many contexts. (15) This reflects ongoing debate about diagnostic thresholds — but cardiovascular risk rises continuously with blood pressure, without a sharp biological boundary.

A diagnosis requires elevated readings on more than one occasion using proper technique. A single high reading is not enough — blood pressure varies throughout the day and can be transiently elevated by stress, caffeine, or the clinical setting.

These categories matter for clinical decision-making. They do not, however, describe biology. A blood pressure of 132/84 at age 28 means something biologically different from the same reading appearing transiently during illness at age 72. Duration of exposure changes what the number means.

Accurate diagnosis depends on accurate measurement, and clinic readings are frequently distorted by technique errors that can shift classification by 5–15 mmHg or more. Article 2 of this series covers how to measure blood pressure properly.

---

Risk Is Continuous, Not Threshold-Based

The relationship between blood pressure and cardiovascular risk is continuous, not binary. There is no threshold below which elevated pressure carries no biological consequence.

From about 115/75 mmHg upward, each 20 mmHg higher usual systolic pressure (or ~10 mmHg higher diastolic) was associated with roughly a two-fold increase in vascular mortality across midlife and into older age — with no clear safe threshold (Prospective Studies Collaboration meta-analysis, ~1 million adults, 61 studies). (16)

This means “normal” is not the same as “optimal.” Blood pressure in the 130s carries more risk than blood pressure in the 110s — even though both fall under the “normal” or “elevated” labels in some categorical systems. Lower is not the same as zero: cardiovascular risk persists across the pressure spectrum, and other risk factors such as smoking, lipids, diabetes, and family history continue to matter regardless of blood pressure. Treatment trials confirm what the observational data suggest: lowering blood pressure reduces events. A 5 mmHg reduction in systolic pressure is associated with approximately a 10% lower risk of major cardiovascular events. (17)

Blood pressure categories are clinical tools, not biological boundaries. Arteries do not suddenly become damaged at 130/80 mmHg. Risk rises gradually across the pressure spectrum.

---

Cumulative Pressure Exposure: Why Years Matter More Than Visits

One of the most clinically important — and most underappreciated — concepts in cardiovascular medicine is that elevated pressure injures vascular tissue over time, and what matters is the total exposure, not the level at any one visit. Endothelial stress, vascular remodeling, and small-vessel injury accumulate incrementally rather than appearing suddenly — each year of elevated pressure adds to what came before.

Consider two people. The first has had blood pressure consistently around 132/84 from age 30 to age 55 — never high enough to alarm any clinician at any particular visit. The second has had blood pressure of 158/96 for the past six months. The second person’s reading is more striking. But the first person’s arterial system has experienced twenty-five years of sustained elevated stress, with persistent activation of the systems that defend higher pressure and progressive remodeling of vessel walls.

The total burden in the first case is larger. The vascular injury continued accumulating throughout that period, even though the numbers never appeared alarming.

The CARDIA study followed young adults for more than 30 years and found that cumulative blood pressure exposure during young adulthood was strongly associated with subsequent cardiovascular events — independent of single-visit blood pressure values. (18) Young adults who maintained blood pressure in the 130s had substantially higher cardiovascular risk decades later than those who maintained pressure in the 110s, even though neither group was classified as hypertensive at the time by traditional definitions.

In practice: a blood pressure of 128/82 may not trigger intervention at any particular clinical visit. But if it has been sustained for ten years, the arterial system has experienced a decade of endothelial stress, pulsatile force amplified at branch points where atherosclerosis preferentially develops, and chronic activation of the systems that defend elevated pressure.

It is also why coronary artery calcium or left ventricular hypertrophy can be present despite “borderline” or “controlled” numbers. The biology does not wait for thresholds. Mildly elevated pressure that persists for years often matters more than dramatically elevated pressure that is recognized and treated quickly.

Earlier reduction in pressure changes trajectory before irreversible vascular remodeling becomes established. The arterial system responds to total lifetime exposure, and the leverage of intervention is greatest while arteries are still biologically responsive.

---

Primary vs. Secondary Hypertension

Primary (essential) hypertension (~90–95% of cases) has no single identifiable cause. It results from interactions among genetics, aging, sodium intake, inactivity, weight gain, kidney function, and arterial stiffness. (19,14) There is rarely one cause — and rarely one simple fix.

Secondary hypertension (~5–10% of cases) is caused by an identifiable condition — obstructive sleep apnea, primary aldosteronism, kidney disease, renovascular disease, or others. Treating the cause can substantially improve blood pressure, though reversal is variable. (14)

Clues that suggest secondary hypertension include onset before age 30 or after age 55, resistant hypertension (poorly controlled despite three or more medications), sudden worsening of previously controlled blood pressure, or unexplained low potassium. Article 5 of this series covers secondary hypertension and its evaluation in detail.

---

Why Hypertension Develops

For most people with primary hypertension, there is no single cause that can be identified and removed. The condition emerges from interactions among multiple factors operating over years to decades.

Partly fixed contributors

Many genes contribute small effects to blood pressure regulation — affecting sodium handling, vascular tone, RAAS activity, and the structure of arterial walls — and family history is associated with substantially higher risk independent of shared lifestyle. (19) Kidney sodium-handling patterns set in early life appear to influence who develops hypertension and who does not, even at similar sodium intakes. Arteries lose elasticity with age, contributing to the rise in systolic pressure observed across the lifespan. None of this is destiny: lifestyle factors and medications still work regardless of genetic background, and many patients with strong family histories achieve excellent long-term control.

Modifiable and often dominant contributors

Excess body weight — particularly fat stored around the abdominal organs — drives hypertension through insulin resistance, sympathetic activation, and renal sodium retention, making weight one of the strongest reversible contributors to blood pressure. Sodium intake matters, though individual responses vary widely. Salt sensitivity — how strongly a person’s pressure responds to changes in sodium — is partly genetic, partly age-related, and more common in older adults, African American patients, and those with chronic kidney disease. The only way to know how a particular person responds is to observe what happens when sodium intake changes meaningfully. Physical inactivity and heavier alcohol intake contribute as well.

Systems that should be quiet but aren’t

Chronic psychological stress, poor sleep, and obstructive sleep apnea elevate sympathetic activity over time. Obstructive sleep apnea is one of the most commonly overlooked drivers of difficult-to-control blood pressure. Certain medications can also push pressure up — NSAIDs, decongestants, some antidepressants, oral contraceptives in some patients, and corticosteroids. In women, a history of preeclampsia, gestational hypertension, or premature menopause is associated with elevated long-term blood pressure risk that often warrants earlier and closer follow-up.

These factors interact rather than add. A patient with a family history of hypertension, gradual weight gain across adulthood, sodium intake above average, untreated sleep apnea, and increasing arterial stiffness with age is not facing one cause — they are facing five or six acting together. Hypertension management is rarely just one intervention because hypertension is rarely just one process.

A note on younger adults

Hypertension increasingly develops earlier in life, sometimes in adolescence or young adulthood — and the cumulative-exposure principle makes early-onset hypertension particularly consequential. Decades of even modestly elevated pressure beginning in young adulthood produce more total arterial exposure by midlife than later-onset hypertension would have produced by the same age. Midlife vascular risk factors, including hypertension, are increasingly recognized as contributors to dementia risk by older age — making early control not only a matter of cardiovascular protection but of cognitive protection as well. (34) This is why modern guidelines take hypertension in younger adults more seriously, not less, and why blood pressure screening matters across the entire adult lifespan.

Article 4 of this series covers these drivers in depth, including the practical question of which ones matter most for whom.

---

Why Office Readings Can Mislead

Two important patterns explain why clinic blood pressure may not reflect the pressure arteries are actually experiencing day to day:

White-coat hypertension. Blood pressure is elevated in clinic but normal outside. Meta-analyses suggest the cardiovascular risk is generally lower than sustained hypertension but higher than true normotension. Estimates vary by definition and follow-up. (20) This pattern can progress over time — one reason repeat and out-of-office measurement matter.

Masked hypertension. Blood pressure appears normal in clinic but is elevated at home, at work, or during sleep. The cardiovascular risk is similar to or higher than sustained hypertension. (21) Much of the arterial damage in masked hypertension occurs during the hours when the cuff is nowhere near the patient.

These patterns explain why home and ambulatory monitoring are increasingly central to modern hypertension care. Article 2 covers measurement technique and out-of-office monitoring in depth.

---

How Hypertension Damages the Body

Hypertension does not damage one organ at a time. It damages the vascular system everywhere simultaneously. The manifestations differ by organ — stroke in the brain, nephrosclerosis in the kidneys, hypertrophy in the heart, atherosclerosis in the coronary arteries — but the underlying process is shared: cumulative vascular injury from chronic pressure exposure.

That damage proceeds through two parallel processes:

• Large artery disease — accelerated atherosclerosis in coronary, cerebral, and peripheral arteries
• Small vessel disease — arteriolar wall thickening, loss of microvessels (rarefaction), and impaired local blood flow regulation

These mechanisms unfold across multiple organ systems over years to decades, often without symptoms.

Endothelial dysfunction: where damage begins

The endothelium — the single-cell lining of all blood vessels — is the earliest site of hypertensive injury. (22)

A healthy endothelium releases nitric oxide, which keeps vessels dilated, limits clotting, and controls inflammation. Chronic elevated pressure and abnormal shear stress — the frictional force from blood flow along the vessel lining — reduce nitric oxide availability, increase permeability to LDL cholesterol, and activate inflammatory pathways. (23) Over years, this shifts the arterial wall toward atherosclerotic plaque formation.

Hypertension and coronary artery disease are tightly linked biologically. Elevated pressure does not merely coexist with plaque formation — it actively creates the endothelial conditions that allow plaque to begin and progress. The links between them are covered in the HeartBuddi CAD series.

Arterial stiffening: the self-reinforcing cycle

Chronic hypertension alters arterial structure over years: elastin fragments, collagen accumulates, smooth muscle enlarges, and walls thicken. (24) Stiff arteries transmit more pulsatile energy directly to downstream tissues, raising systolic pressure further and widening pulse pressure (the gap between systolic and diastolic). (25)

This creates a self-reinforcing cycle. Hypertension stiffens arteries, and stiff arteries amplify systolic pressure further by reflecting pulsatile energy back toward the heart more rapidly. Over years, the vascular system gradually shifts from an elastic reservoir designed to buffer pulsatile flow into a rigid conduit that transmits damaging pressure more directly into the heart, brain, and kidneys. This is one reason systolic blood pressure tends to rise with age while diastolic pressure may plateau or fall — the pattern recognized clinically as isolated systolic hypertension, which becomes the dominant form of hypertension after about age 60 and reflects vascular aging more than any acute physiologic disturbance.

Arterial stiffening connects much of what this series will return to: endothelial dysfunction, widened pulse pressure, cumulative exposure, and the gradual loss of vascular elasticity that defines vascular aging. Once stiffening is established, it becomes one of the most difficult features of hypertension to reverse — which is one of the strongest arguments for treating elevated pressure before it accumulates.

---

The Compensation That Hides the Damage

Early in hypertension, the arterial system and the heart compensate remarkably well. Arterial walls remodel. The left ventricle thickens to maintain forward output against higher resistance. The kidneys adjust sodium handling. Organs continue to function normally despite increasing biological strain.

The absence of symptoms often reflects successful compensation, not the absence of injury. By the time symptoms appear, compensation has typically been failing for years. A first heart attack, a first stroke, advanced left ventricular hypertrophy on an echocardiogram, or emerging kidney dysfunction is usually not a new event — it is the late phase of a process that began much earlier.

Because vascular damage develops gradually while the blood pressure number is what clinicians can directly measure, assessing trajectory requires knowing what the pressure has been doing over years, not just at a single visit.

---

The Pattern Across Organs: Injury, Compensation, Consequence

Hypertension’s effects accumulate through a consistent pattern across organ systems: a mechanism of injury, an early compensation that hides the damage, and a long-term consequence that becomes apparent only after compensation fails.

Mechanism of injury	Early compensation	Long-term consequence
Increased arterial pressure on vessel walls (24)	Arterial wall remodeling and thickening	Arterial stiffness, widened pulse pressure (25)
Left ventricular pressure overload (26)	Concentric left ventricular hypertrophy	Diastolic dysfunction, heart failure, arrhythmia (27,29)
Coronary endothelial injury and shear stress (22,23)	Preserved coronary flow at rest	Accelerated atherosclerosis, myocardial infarction (25)
Cerebral small vessel pressure exposure (33)	Cerebral autoregulation maintains flow	White matter disease, lacunar stroke, cognitive impairment (33,34)
Renal microvascular injury (35)	Sodium retention adjusts	Nephrosclerosis, chronic kidney disease, kidney failure (35,36)
Aortic wall mechanical stress (37)	Aortic remodeling and dilation	Aortic aneurysm, dissection (37)
Retinal microvascular injury (38)	Visual function preserved	Hypertensive retinopathy, predictive of CV events (38)
Coronary microvascular injury (39)	Coronary flow reserve adequate at rest	Impaired flow reserve under exertion, angina with normal angiogram (40)

The heart

Hypertension affects the heart through three parallel pathways.

Coronary artery disease. Hypertension accelerates atherosclerosis and is a major modifiable risk factor for myocardial infarction. Pressure injures the endothelium; injured endothelium allows LDL retention; retained LDL drives the inflammatory cascade that forms plaque. Chronic pressure exposure contributes directly to the endothelial injury where plaque formation begins. (25)

Left ventricular hypertrophy. The heart thickens to cope with chronic pressure overload. Initially this preserves output. Over time the thickened, stiffer ventricle fills less effectively, demands more oxygen, and becomes more vulnerable to arrhythmias. Sustained blood pressure control can partially reverse left ventricular hypertrophy. (26–28)

Heart failure. Hypertension precedes most cases of heart failure. It contributes to both preserved and reduced ejection fraction phenotypes — but particularly to heart failure with preserved ejection fraction, where the underlying problem is a stiff ventricle that cannot fill properly even though it pumps adequately. (29,30)

The brain

Hypertension is the most important modifiable risk factor for both ischemic and hemorrhagic stroke. It also damages small cerebral vessels over years, producing white matter disease, microinfarcts, and structural changes that increase dementia risk decades later. (31–34) Cumulative blood pressure exposure in midlife is increasingly recognized as one of the most consequential preventable contributors to cognitive decline — a process that often begins damaging the cerebral microcirculation decades before cognitive symptoms appear.

The kidneys

Hypertension causes progressive nephrosclerosis — narrowing of small renal vessels and loss of nephrons over time. This creates a vicious cycle: damaged kidneys impair sodium handling and contribute to worse blood pressure control, which damages the kidneys further. (35,36) In many patients, hypertension and kidney disease accelerate each other in a way that is difficult to interrupt once it is established.

The aorta

Chronic hypertension is one of the most important contributors to aortic aneurysm and aortic dissection, though not the only one — genetic conditions affecting connective tissue (such as Marfan and Loeys-Dietz syndromes), bicuspid aortic valve, and prior aortic disease also matter. (37) The aorta is built to absorb the force of each heartbeat; sustained pressure overload weakens this structural function over years. Aortic dissection can be rapidly fatal — one of the situations where decades of silent vascular injury produce a sudden, catastrophic event.

The eyes

The retinal vessels are visible. They are also a window into systemic vascular health. Hypertensive retinopathy — the structural changes visible on a retinal examination in chronic hypertension — independently predicts cardiovascular events. (38) What the eye doctor sees in the retina reflects what is happening, less visibly, throughout the rest of the arterial tree.

The coronary microcirculation

Hypertension injures not only the large coronary arteries but also the coronary microvasculature. As pulse pressure widens, the damaging pulsatile energy that would normally be absorbed by elastic large vessels reaches smaller vessels, impairing coronary flow reserve — the heart’s ability to increase blood supply during exertion — even when standard angiography appears normal. (39,40)

This helps explain a clinical pattern that frustrates many patients: chest symptoms and exertional limitation in someone whose coronary catheterization is read as “clean.” The large arteries can look normal while the microvasculature has already been injured for years.

---

The Silent Phase

One of the most dangerous features of hypertension is how biologically quiet it can remain while damage accumulates. Patients often feel completely normal while endothelial dysfunction progresses, left ventricular thickening develops, kidney injury advances, and plaque progression continues for years.

Hypertension usually causes no symptoms until organ damage is advanced. (14) Headache, dizziness, or flushing correlate poorly with actual blood pressure. (41) Patients sometimes assume they can tell when their blood pressure is up — but extensive evidence shows that symptoms are unreliable indicators of pressure at any given moment.

For many patients, the first sign of hypertension is a heart attack, a stroke, kidney failure, or the discovery of cardiac remodeling on an imaging study performed for some other reason. Arteries do not produce symptoms when they are being damaged. The only way to know your blood pressure is to measure it — accurately, repeatedly, and in the context of how long it has been at that level.

This is the educational core of Article 2: measurement quality, technique, home monitoring, and how to recognize when clinic readings are unreliable.

---

Hypertensive Crisis

Clinicians commonly use ≥180/120 mmHg as a threshold that may signal a crisis — especially if symptoms are present. (14)

Hypertensive emergency. Severe elevation accompanied by acute organ damage — stroke, heart attack, acute heart failure, aortic dissection, eclampsia, or acute kidney injury. Immediate treatment is required, typically with intravenous medications in a hospital setting. (42)

Hypertensive urgency. Severe elevation without acute organ damage. This still requires prompt clinical evaluation. Some recent statements prefer the term “markedly elevated blood pressure” for this scenario, reserving “emergency” for cases with active organ injury. (42)

Not every severe elevation represents immediate organ injury, and some patients with chronically uncontrolled hypertension can appear relatively well despite markedly elevated readings. The clinical concern is whether acute vascular injury is occurring — which is why symptoms, examination findings, neurologic changes, chest pain, signs of pulmonary edema, acute kidney injury, and retinal findings all matter at the bedside. A reading of 200/110 in a patient who feels well, has no neurologic changes, and has a stable examination is a different clinical situation from the same reading in a patient with chest pain or focal weakness.

When to act on a home reading. If you have a home reading of 180/120 or above, contact your clinician. If you have a reading at that level with symptoms — chest pain, severe shortness of breath, sudden severe headache, neurologic changes, or vision changes — call emergency services.

---

What This Means

Hypertension is usually not a sudden disease. It is mechanical force applied to the arterial system continuously over years — often without symptoms, often while the body appears to function normally. The arterial system tolerates normal pulsatile pressure indefinitely. It does not tolerate chronic excess pressure without remodeling, stiffening, and accumulating injury across every vascular bed in the body.

The danger sits in total exposure, not in any single reading. Cardiovascular disease is rarely the result of one abnormal value or one acute event — it is the consequence of years of pressure injury, vascular remodeling, and inflammation acting together. Hypertension is one of the most common, most consequential, and most modifiable contributors to that process. The fact that it operates without symptoms is not a reason to wait — it is the reason measurement, accurate diagnosis, and sustained control matter long before clinical disease appears.

Lowering blood pressure reduces stroke, heart failure, kidney disease, and coronary events — substantially and across the entire pressure spectrum. The benefit is greatest when intervention begins before irreversible vascular remodeling is established, but improvement is meaningful at any stage of disease and at any age. A reading that has improved with treatment is the medication working, not the underlying biology disappearing. The regulatory systems that defended the elevated pressure remain calibrated to defend it, and stopping treatment because the number looks good usually returns pressure to where it was. Sustained control over years is what changes outcomes, not control over a single visit.

Pressure is not just a number. It is physical force applied to the arterial system thousands of times per day, and the effect of that force over years is what blood pressure treatment is designed to change.

This is the foundation for everything that follows in the series. Article 2 covers measurement — how to know what your blood pressure actually is, since accurate measurement is the prerequisite for everything else. Article 3 covers the science of blood pressure control in more depth. Article 4 covers the lifestyle and biological drivers that push pressure up over time. Articles 5 through 9 cover secondary causes, evidence-based lifestyle interventions, medications, environmental contributors, and the practical work of long-term control.

---

Key Terms

Adventitia: The outermost arterial wall layer, providing structural support and anchoring the artery to surrounding tissues.

Baroreceptor reflex: Rapid blood pressure regulation via pressure sensors in the carotid arteries and aortic arch that signal the brainstem to adjust heart rate and vascular tone.

Cardiac output: Volume of blood pumped by the heart per minute; determined by heart rate × stroke volume.

Coronary flow reserve: The heart’s ability to increase coronary blood flow during stress or exertion above its resting level.

Cumulative pressure exposure: The total mechanical force the arterial system has experienced across years; a more biologically accurate predictor of long-term cardiovascular risk than single-visit measurements.

Diastolic blood pressure: Minimum pressure between heartbeats, when the heart is relaxed and refilling; the bottom number.

Endothelium: Single-cell layer lining all blood vessels; regulates vascular tone, permeability, clotting, and inflammation.

Endothelial dysfunction: Impaired endothelial function, typically with reduced nitric oxide availability and increased inflammation; an early step in atherosclerosis.

Hypertensive emergency: Severe blood pressure elevation with acute organ damage; requires immediate treatment.

Hypertensive urgency: Severe blood pressure elevation without acute organ damage; requires prompt clinical evaluation. Some recent statements prefer the term “markedly elevated blood pressure.”

Intima: The innermost arterial wall layer, lined by endothelium.

Isolated systolic hypertension: Elevated systolic blood pressure with normal or low diastolic pressure; the most common form of hypertension in older adults and a marker of arterial stiffening.

Left ventricular hypertrophy: Thickening of the left ventricle in response to chronic pressure overload; initially adaptive, eventually maladaptive.

Masked hypertension: Blood pressure normal in clinic but elevated outside the medical setting; carries cardiovascular risk similar to or higher than sustained hypertension.

Media: The middle arterial wall layer containing smooth muscle and elastic fibers; contracts and relaxes to change vessel diameter.

Peripheral vascular resistance: Resistance to blood flow through the arterial system, primarily determined by arteriolar tone.

Pressure natriuresis: The kidney’s mechanism of excreting more sodium when blood pressure rises; shifted upward in hypertension so that higher pressure is required to maintain sodium balance.

Primary (essential) hypertension: Elevated blood pressure without an identifiable underlying cause; accounts for approximately 90–95% of cases.

Pulse pressure: The difference between systolic and diastolic blood pressure; widens with arterial stiffening and reflects pulsatile load on the vasculature.

Renin–angiotensin–aldosterone system (RAAS): Hormonal cascade regulating blood pressure and sodium balance; chronically activated in many forms of hypertension.

Salt sensitivity: Individual variation in how strongly blood pressure responds to changes in sodium intake; partly genetic and partly related to age, kidney function, and metabolic health.

Secondary hypertension: Elevated blood pressure caused by an identifiable condition such as obstructive sleep apnea, primary aldosteronism, or renal artery stenosis; accounts for approximately 5–10% of cases.

Systolic blood pressure: Peak pressure during ventricular contraction; the top number.

Vascular aging: The progressive structural and functional decline of arteries over time — including endothelial dysfunction, elastin loss, and increased stiffness — that drives the rise in systolic pressure across the lifespan.

White-coat hypertension: Blood pressure elevated in clinic but normal outside the medical environment; carries some cardiovascular risk but generally less than sustained hypertension.

---

References

1. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier; 2021.
2. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? Circulation. 2001;103(9):1245–1249.
3. Oparil S, Acelajado MC, Bakris GL, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014.
4. Klabunde RE. Cardiovascular Physiology Concepts. 3rd ed. Wolters Kluwer; 2021.
5. Pugsley MK, Bhattacharya S, Knight R, Gilbert JC. Introduction to the cardiovascular system. In: Bhattacharya S, ed. Pharmacology and the Cardiovascular System. Elsevier; 2022.
6. Chapleau MW, Li Z, Meyrelles SS, Ma X, Bhangoo SK. Mechanisms determining sensitivity of baroreceptor afferents in health and disease. Ann N Y Acad Sci. 2001;940:1–19.
7. Lohmeier TE, Iliescu R. The baroreflex as a long-term controller of arterial pressure. Physiology (Bethesda).2015;30(2):148–158.
8. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens. 1998;16(12 Pt 2):1979–1987.
9. Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res.2015;116(6):976–990.
10. Atlas SA. The renin–angiotensin–aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8 Suppl B):9–20.
11. Guyton AC. Blood pressure control — special role of the kidneys and body fluids. Science. 1991;252(5014):1813–1816.
12. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104(4):545–556.
13. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens.1988;1(4 Pt 1):335–347.
14. Jones DW, Ferdinand KC, Taler SJ, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension.2025;82(10):e212–e316. (Co-published in J Am Coll Cardiol 2025;86(18):1567–1678 and Circulation2025;152:e114–e218.)
15. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
16. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913.
17. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967.
18. Nwabuo CC, Vasan RS, Tsao CW, et al. Long-term cumulative blood pressure in young adults and incident heart failure, coronary heart disease, stroke, and cardiovascular disease: the CARDIA study. Eur J Prev Cardiol.2022;29(7):1047–1056.
19. Ehret GB, Caulfield MJ. Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J.2013;34(13):951–961.
20. Huang Y, Huang W, Mai W, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35(4):677–688.
21. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens. 2011;24(1):52–58.
22. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
23. Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease — a 30th anniversary update. Acta Physiol (Oxf). 2017;219(1):22–96.
24. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;107(22):2864–2869.
25. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107(1):139–146.
26. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med. 1992;327(14):998–1008.
27. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J.2001;141(3):334–341.
28. Pierdomenico SD, Cuccurullo F. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am J Hypertens. 2010;23(8):876–881.
29. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557–1562.
30. Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary concepts. JACC Heart Fail. 2017;5(8):543–551.
31. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics — 2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254–e743.
32. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(4):1024–1033.
33. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.
34. Gottesman RF, Albert MS, Alber J, et al. Associations between midlife vascular risk factors and 25-year incident dementia in the ARIC cohort. JAMA Neurol. 2017;74(10):1246–1254.
35. Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17(3):266–270.
36. Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension.2004;44(5):595–601.
37. Golledge J, Eagle KA. Acute aortic dissection. Lancet. 2008;372(9632):55–66.
38. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351(22):2310–2317.
39. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830–840.
40. Taqueti VR, Di Carli MF. Coronary microvascular disease: pathogenic mechanisms and therapeutic options. J Am Coll Cardiol. 2018;72(21):2625–2641.
41. Fuchs FD, Gus M, Moreira WD, et al. Headache is not more frequent among patients with moderate to severe hypertension. J Hum Hypertens. 2003;17(11):787–790.
42. van den Born BJH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37–46.